New studies gauge knowledge, attitudes and preferences of patients with irritable bowel syndromeOctober 31, 2005Significant percentage mistakenly believe IBS causes cancer HONOLULU - Significant misconceptions about the causes of their condition and mistaken beliefs about its potential progression into other diseases, including cancer, marks the knowledge of a sample of patients with Irritable Bowel Syndrome (IBS) in two recent studies by researchers at Dartmouth-Hitchcock Medical Center in New Hampshire. Presented at the 70th Annual Scientific Meeting of the American College of Gastroenterology, these studies echo findings presented at ACG by Dr. Albena Halpert of Boston Medical Center and colleagues at the University of North Carolina at Chapel Hill on patient perceptions of IBS and their preferences about patient education. Dartmouth-Hitchcock Study Finds Significant Concerns and Misconceptions "IBS is one of the most common medical conditions, and our study reveals that a lot of people are facing a problem, they don't feel well, they have significant concerns, and they don't have enough information," said Brian E. Lacy, Ph.D., M.D., one of the investigators at Dartmouth-Hitchcock who conducted two separate analyses of 261 respondents to study questionnaires. In one analysis, Dr. Lacy and his colleagues found that almost half (42.9 percent) of respondents believed that IBS develops due to food allergy or intolerance, while an even larger percentage (82 percent) reported that a change in their daily routine causes IBS. Significant misconceptions were identified regarding the natural history of IBS, with one-third of respondents believing that once IBS develops it will never resolve, and 16.7 percent expressing the belief that IBS will turn into cancer. Of these patients, 87 percent reported that IBS significantly affects their lives, with daily activities (40.1 percent), work life (19.3 percent) and social life (11.2 percent) being the most frequently affected. In a related study of the same survey respondents, Dr. Lacy and his colleagues found that this sample of patients with IBS did not understand the causes of their condition. A large percentage cited dietary factors (80.7 percent), anxiety (87.9 percent), and depression (68.2) as the most frequent causes of IBS. IBS patients in this study believe that IBS increases the risk of colon cancer (21.5 percent) and increases the risk of Inflammatory Bowel Disease (30.5 percent). IBD is an inflammatory condition of the intestine that can result in bleeding, fever, elevation of the white blood cell count, as well as diarrhea and cramping abdominal pain. IBD includes ulcerative colitis and Crohn's disease. "This is the first study to assess IBS patients' knowledge regarding their disorder. Our findings highlight the need for effective educational programs for IBS patients," concluded Dr. Lacy. National Survey on Patient Education in IBS Albena Halpert, M.D. of Boston Medical Center and Douglas Drossman, M.D., FACG of the University of North Carolina at Chapel Hill developed and fielded a questionnaire to identify patients' perceptions about IBS, their preferences on the type of information they need, as well as educational media and expectations from health care providers. Responses from 200 patients with IBS revealed misperceptions about IBS developing into other conditions, including colitis, malnutrition and cancer. This survey found IBS patients were most interested in learning about foods to avoid (60 percent), causes of IBS (55 percent), medications (58 percent), coping strategies (56 percent), and psychological factors related to IBS (55 percent). The respondents indicated that they wanted their physician to be available via phone or e-mail following a visit (80 percent) and have the ability to listen (80 percent), provide hope (73 percent) and support (63 percent). About Irritable Bowel Syndrome IBS is a functional gastrointestinal (GI) disorder characterized by recurring symptoms of abdominal discomfort or pain associated with an altered bowel habit, either constipation, diarrhea, or both. More than 58 million people suffer from IBS, which affects more women (80%) than men. IBS is a real medical condition, but it is not life threatening, and will not lead to other serious diseases. In IBS, the GI tract may function differently, processing more slowly (or more quickly) than the average person. While the cause of this different "pace" of the GI tract in IBS is not known, and there is no cure, there are usually ways to help manage specific symptoms. Physicians now have more scientific knowledge and an improved range of treatment options that can provide relief for IBS sufferers. The American College of Gastroenterology has resources for patients with IBS online at www.ibsrelief.org and free educational materials are available by calling ACG's toll-free hotline 866-IBS-RELIEF. American College of Gastroenterology |
|||||||||||||||||||||
| Related Irritable Bowel Syndrome Current Events and Irritable Bowel Syndrome News Articles Antidepressant and placebo are equally effective in child pain relief When used "off-label," the antidepressant amitriptyline works just as well as placebo in treating pain-predominant gastrointestinal disorders in children, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. What is alternative treatment for irritable bowel syndrome when conventional therapy has failed? IBS remains a common intestinal disorder causing significant discomfort and poor quality of life in patients who have the diagnosis. Pinpointing cause of colic: UT Houston research identifies organism that could trigger constant crying Researchers at The University of Texas Health Science Center at Houston say one organism discovered during their study may unlock the key to what causes colic, inconsolable crying in an otherwise healthy baby. Mayo Clinic study finds celiac disease 4 times more common than in 1950s Celiac disease, an immune system reaction to gluten in the diet, is over four times more common today than it was 50 years ago, according to findings of a Mayo Clinic study published this month in the journal Gastroenterology. Review of probiotic trial research finds only Bifantis able to claim efficacy for IBS symptoms A review by researchers at Northwestern University (Chicago, IL.) and University of Michigan (Ann Arbor, MI) of the utility of probiotics in the treatment of Irritable Bowel Syndrome (IBS) found that Bifidobacterium infantis 35624 was the only probiotic strain out of 13 different individual strains or preparations reviewed to significantly improve symptoms of IBS, including abdominal pain, bloating and bowel movement difficulty. New studies examine the effectiveness of probiotics in IBS Several studies presented at the American College of Gastroenterology's 73rd Annual Scientific Meeting in Orlando highlight the safety and efficacy of probiotics in improving symptoms and normalizing bowel movement frequency in patients suffering from constipation or diarrhea related to Irritable Bowel Syndrome (IBS). New study shows health benefits of probiotic could extend to the entire body Data from a recent study demonstrate the anti-inflammatory and pathogen protection benefits of Bifidobacterium infantis 35624 a probiotic bacterial strain of human origin. UT School of Public Health researchers discover significant efficacy of travelers' diarrhea vaccine Researchers at The University of Texas School of Public Health have found that patients given a travelers' diarrhea vaccine were significantly less likely to suffer from clinically significant diarrhea than those who received placebo, according to a study published in this week's edition of the Lancet. The patch-based vaccine is part of the Phase 2 study in conjunction with the Iomai Corporation. Common bowel problem linked to chili pepper pain receptor People with irritable bowel syndrome have a higher than usual number of chilli pepper pain receptors, according to a new study published tomorrow (Wednesday 11 June). Drug brings relief for many IBS patients who experience constipation Many patients may soon find relief from the bloating, cramping, abdominal pain and constipation associated with irritable bowel syndrome, or IBS. More Irritable Bowel Syndrome Current Events and Irritable Bowel Syndrome News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||